Real World Experience of Standard of Care Talquetamab in Patients with Relapsed and Refractory Multiple Myeloma

被引：0
|
作者：
Grajales-cruz, Ariel [1 ]
Graeter, Allison [2 ]
Hansen, Doris [1 ]
Puglianini, Omar Castaneda [1 ]
Vazquez-Martinez, Mariola [1 ]
Blue, Brandon [1 ]
Liu, Hien [1 ]
Ochoa-Bayona, Jose [1 ]
Freeman, Ciara [1 ]
Locke, Frederick [1 ]
Nishihori, Taiga [1 ]
Shain, Kenneth [1 ]
Baz, Rachid [1 ]
Alsina, Melissa [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Tampa, FL 33620 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-027
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [1] A German Multicenter Real-World Analysis of Talquetamab in 102 Patients With Relapsed/ Refractory Multiple Myeloma
    Frenking, Jan
    Riedhammer, Christine
    Besemer, Britta
    Braune, Jan
    Brioli, Annamaria
    Brunner, Franziska
    Dampmann, Maria
    Gezer, Deniz
    Goldman-Mazur, Sarah
    Haenel, Mathias
    Hanoun, Christine
    Hoegner, Marion
    Kolditz, Katja
    Kos, Igor
    Kull, Miriam
    Leitner, Theo
    Merz, Maximilan
    von Metzler, Ivana
    Michel, Christian S.
    Teipel, Raphael
    Theurich, Sebastian
    Waesch, Ralph
    Zukovs, Romans
    Rasche, Leo
    Raab, Marc-Steffen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S52 - S53
  • [2] Real world Experience of Talquetamab in Relapsed Refractory Myeloma, First Report From the IMWG Consortium
    Janakiram, Murali
    Tan, Carlyn
    Popat, Rakesh
    Kastritis, Efstathios
    Martinez-Lopez, Joaquin
    Shekarkhand, Tala
    Bansal, Radhika
    Corraes, Andre De Menezes Silva
    Corona de la Puerta, Magdalena
    Saez Marin, Adolfo J.
    Htut, Myo
    Fotiou, Despina
    Dimopoulos, Meletios
    Chowdhury, Arnab
    Kumar, Shaji
    Martin, Thomas
    Krishnan, Amrita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S60 - S61
  • [3] Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
    Shaikh, Hira
    Lochner, Jonathan
    Friend, Reed
    Snyder, Jordan
    Davis, James
    Patrus, Gina
    Dileo, Rachel
    Ahmed, Nausheen
    Mewawalla, Prerna
    Poonsombudlert, Kittika
    Struble, Emily
    Wolcott, Allyson
    Green, Kimberly
    Sparrow, Samantha
    Mushtaq, Muhammad Umair
    Paul, Barry
    Abdallah, Al-Ola
    Strouse, Christopher
    Hashmi, Hamza
    Atrash, Shebli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S87 - S88
  • [4] Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma
    Costa, Bruno
    Tan, Carlyn
    Shekarkhand, Tala
    Firestone, Ross
    Jurgens, Eric
    Miller, Kevin
    Lesokhin, Alexander
    Shah, Gunjan
    Korde, Neha
    Rajeeve, Sridevi
    Chung, David
    Landau, Heather
    Scordo, Michael
    Hassoun, Hani
    Maclachlan, Kylee
    Shah, Urvi
    Hultcrantz, Malin
    Hamadeh, Issam
    Giralt, Sergio
    Mailankody, Sham
    Usmani, Saad
    Hashmi, Hamza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S46 - S47
  • [5] Real-world experience with clinical management of talquetamab in relapsed/refractory multiple myeloma: a qualitative study of US healthcare providers
    Schinke, Carolina
    Dhakal, Binod
    Mazzoni, Sandra
    Shenoy, Samantha
    Scott, Sara A.
    Richards, Tiffany
    Le, Hoa H.
    DeBrosse, Amalia
    Okorozo, Peter
    McDowell, Rachel
    Patel, Saurabh
    Bunn, Jonathan
    Hawks, Kelly
    Zhang, Xinke
    Rodriguez, Cesar
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (10) : 1705 - 1711
  • [6] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
    Hultcrantz, Malin
    Orozco, Jennifer
    Peterson, Tim J.
    Derkach, Andriy
    Hassoun, Hani
    Korde, Neha
    Lu, Sydney X.
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Maclachlan, Kylee H.
    Chung, David J.
    Landau, Heather J.
    Shah, Gunjan L.
    Lahoud, Oscar B.
    Scordo, Michael
    Landgren, Ola
    Giralt, Sergio
    Lesokhin, Alexander
    BLOOD, 2021, 138
  • [7] Daratumumab triplet therapies in patients with relapsed or refractory multiple myeloma: A "real world" experience
    Fucci, Ludovica
    Gensini, Lorenzo
    Coppetelli, Ugo
    La Barbera, Elettra Ortu
    Gentile, Martina
    Fiori, Luciano
    Perrone, Salvatore
    Cimino, Giuseppe
    LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [8] Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma
    Costa, Bruno Almeida
    Tan, Carlyn Rose
    Shekarkhand, Tala
    Firestone, Ross S.
    Jurgens, Eric M.
    Miller, Kevin
    Lesokhin, Alexander M.
    Shah, Gunjan L.
    Korde, Neha
    Rajeeve, Sridevi
    Chung, David J.
    Landau, Heather J.
    Scordo, Michael
    Hassoun, Hani
    Maclachlan, Kylee H.
    Shah, Urvi A.
    Hultcrantz, Malin
    Hamadeh, Issam S.
    Giralt, Sergio
    Mailankody, Sham
    Usmani, Saad Z.
    Hashmi, Hamza
    BLOOD, 2024, 144 : 7026 - 7027
  • [9] Real world experience with "generic" pomalidomide in relapsed refractory multiple myeloma
    Jandial, Aditya
    Mishra, Kundan
    Lad, Deepesh
    Prakash, Gaurav
    Khadwal, Alka
    Malhotra, Pankaj
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1102 - 1104
  • [10] Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab
    Chari, Ajai
    Krishnan, Amrita
    Rasche, Leo
    Ye, Jing Christine
    Garfall, Alfred
    Popat, Rakesh
    Lipe, Brea
    Qin, Xiang
    Campagna, Michela
    Masterson, Tara
    Tomlinson, Chalmer
    Hilder, Brandi
    Tolbert, Jaszianne
    Renaud, Thomas
    Smit, M. Damiette
    Gray, Kathleen
    Kane, Colleen
    Heuck, Christoph
    van de Donk, Niels W. C. J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10): : 665 - +
12345